ICU Medical Inc (ICUI)
Profitability ratios
Return on sales
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross profit margin | 32.75% | 33.04% | 32.51% | 31.27% | 30.60% | 31.84% | 33.23% | 35.53% | 37.34% | 37.33% | 36.76% | 35.92% | 36.31% | 36.00% | 36.69% | 36.24% | 37.27% | 38.14% | 38.79% | 40.94% |
| Operating profit margin | 1.01% | 1.55% | 0.50% | 0.38% | -1.88% | -0.92% | 1.12% | 3.54% | 9.36% | 9.75% | 8.88% | 7.83% | 7.72% | 7.03% | 7.68% | 8.15% | 8.48% | 6.23% | 3.80% | 4.06% |
| Pretax margin | -3.47% | -2.80% | -3.44% | -3.17% | -5.02% | -3.41% | -0.58% | 2.68% | 9.36% | 10.03% | 9.24% | 8.27% | 7.67% | 6.97% | 7.56% | 8.04% | 9.06% | 6.30% | 3.81% | 3.83% |
| Net profit margin | -1.31% | -1.25% | -2.11% | -2.00% | -3.26% | -1.90% | 0.31% | 2.68% | 7.84% | 8.44% | 8.07% | 7.44% | 6.83% | 6.43% | 6.61% | 6.87% | 7.98% | 5.66% | 3.56% | 4.04% |
ICU Medical, Inc. has shown a fluctuating trend in its profitability ratios over the past eight quarters. The company's gross profit margin has ranged between 30.60% and 33.04%, with Q3 2023 showing the highest margin at 33.04%. This indicates the company's ability to generate profit from its core operations, although there was a slight decrease in Q4 2023 compared to the previous quarters.
In terms of operating profit margin, ICU Medical, Inc. has experienced variability, with Q1 2022 showing the highest margin at 6.72% and Q4 2022 recording a negative margin of -0.16%. Despite the fluctuations, the company has managed to maintain positive operating margins in most quarters, indicating some level of operational efficiency in managing expenses.
The pretax margin for ICU Medical, Inc. has also displayed inconsistency, with Q1 2022 and Q3 2022 showing positive margins of 2.68% and -0.58%, respectively. However, the company recorded negative pretax margins in the following quarters. This suggests that ICU Medical, Inc. faced challenges in generating income before taxes across some periods.
Lastly, the net profit margin of ICU Medical, Inc. has shown a similar trend of fluctuation, with varying results between negative and positive margins. Q2 2022 recorded the highest net profit margin at 0.31%, while Q4 2022 had the lowest margin of -3.26%. Overall, the company's profitability ratios indicate a mixed performance in terms of generating profits after accounting for all expenses and taxes.
Return on investment
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating return on assets (Operating ROA) | 0.52% | 0.79% | 0.26% | 0.19% | -0.95% | -0.42% | 0.44% | 1.15% | 6.55% | 6.87% | 6.30% | 5.59% | 5.57% | 5.14% | 5.18% | 5.67% | 6.34% | 4.91% | 3.07% | 3.42% |
| Return on assets (ROA) | -0.68% | -0.64% | -1.09% | -1.03% | -1.65% | -0.87% | 0.12% | 0.87% | 5.48% | 5.95% | 5.73% | 5.31% | 4.93% | 4.70% | 4.46% | 4.78% | 5.97% | 4.46% | 2.88% | 3.40% |
| Return on total capital | 0.46% | 0.79% | 0.18% | 0.11% | -1.26% | -0.63% | 0.50% | 1.44% | 7.68% | 8.22% | 7.66% | 6.97% | 6.61% | 6.20% | 6.81% | 7.43% | 8.37% | 6.11% | 3.85% | 4.11% |
| Return on equity (ROE) | -1.40% | -1.34% | -2.29% | -2.19% | -3.55% | -1.93% | 0.26% | 1.90% | 6.38% | 6.88% | 6.63% | 6.17% | 5.78% | 5.60% | 5.88% | 6.31% | 7.34% | 5.45% | 3.54% | 4.28% |
ICU Medical, Inc.'s profitability ratios show a mix of positive and negative performance over the past eight quarters.
The operating return on assets (Operating ROA) has shown variability, ranging from -0.08% to 1.41%. Despite some fluctuations, the trend has generally been positive, with the ratio improving in recent quarters, indicating that the company is generating more operating income from its assets.
On the other hand, the Return on Assets (ROA) has been consistently negative, ranging from -1.65% to -0.64%. This suggests that the company is not efficiently utilizing its assets to generate profits. However, there has been a slight improvement in the most recent quarters.
The Return on Total Capital has also shown fluctuations but has generally been positive, indicating that the company is generating returns on the total capital employed in its operations. The ratio has ranged from -0.10% to 2.70%, with a noticeable improvement in the most recent quarter.
Lastly, the Return on Equity (ROE) has been negative throughout all the quarters, ranging from -3.55% to -1.34%. This indicates that the company is not generating positive returns for its shareholders based on the equity invested. There has been a slight improvement in the most recent quarter, but overall, the company's performance in terms of ROE remains weak.
In conclusion, while ICU Medical, Inc. has shown some improvements in operating efficiency and returns on total capital, its profitability ratios, especially ROA and ROE, suggest that there is room for enhancement in utilizing assets and generating returns for shareholders.